{
    "nct_id": "NCT06593665",
    "official_title": "Randomized Prospective Study Comparing Intrathecal Morphine Vs Intravenous Methadone for Postoperative Analgesia Following Retroperitoneal Lymph Node Dissection (RPLND)",
    "inclusion_criteria": "* Patients undergoing a virgin (chemotherapy has not been used) or post- chemotherapy retroperitoneal lymph node dissection for primary testicular cancer at IU Health AAHC\n* ASA Class 1, 2, 3\n* Age 18 to 80 years; Male\n* BMI less than 50kg/m2\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years\nMust have maximum age of 80 Years",
    "exclusion_criteria": "* Any contraindication for neuraxial analgesia\n* Patient on home methadone at any dose\n* Any physical, mental or medical conditions which, in the opinion of the investigators, may confound quantifying postoperative pain resulting from surgery.\n* Known true allergy to the study medications (morphine, bupivacaine, acetaminophen, methadone)\n* Any history of substance abuse in the past 6 months which would include heroin or any other illegal street drugs\n* End stage liver disease, end stage renal disease\n* Patient staying intubated after surgery\n* Patient (home dose) taking more than 30mg PO morphine equivalent (PME) per day\n* Any additional surgical procedures to the patient with a different surgical incision compared to the standard laparotomy for the RPLND procedure, i.e. thoracic tumor reduction",
    "miscellaneous_criteria": ""
}